コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 n in human beta-cardiac myosin II results in familial hypertrophic cardiomyopathy).
2 lic dysfunction resembling the human form of familial hypertrophic cardiomyopathy.
3 nse mutations in alpha-tropomyosin can cause familial hypertrophic cardiomyopathy.
4 n gene have been shown to be responsible for familial hypertrophic cardiomyopathy.
5 al proportion (30-40%) of genotyped cases of familial hypertrophic cardiomyopathy.
6 ons in the cardiac gene are a major cause of familial hypertrophic cardiomyopathy.
7 cause both dilated cardiomyopathy (DCM) and familial hypertrophic cardiomyopathy.
8 mutations in human alpha-cardiac actin cause familial hypertrophic cardiomyopathy.
9 ardiac troponin I (cTnI) mutations can cause familial hypertrophic cardiomyopathy.
10 in cTnT have been linked to severe forms of familial hypertrophic cardiomyopathy.
11 ith an R146G mutation [cTnI(146G)] linked to familial hypertrophic cardiomyopathy.
12 associated with a clinically severe form of familial hypertrophic cardiomyopathy.
13 A63V and K70T, each previously implicated in familial hypertrophic cardiomyopathy.
14 mutant myosins found in disease states like familial hypertrophic cardiomyopathy.
15 the cardiac MyBP-C gene are associated with familial hypertrophic cardiomyopathy.
16 in-II mutation responsible for some forms of familial hypertrophic cardiomyopathy.
17 troponin I (cTnI) have been associated with familial hypertrophic cardiomyopathy.
18 diac motor protein genes are associated with familial hypertrophic cardiomyopathy.
19 gotes may account for focal myocyte death in familial hypertrophic cardiomyopathy.
20 property that may be a general phenomenon in familial hypertrophic cardiomyopathy.
21 utations within the gene have been linked to familial hypertrophic cardiomyopathy.
22 xhibit the histopathologic features of human familial hypertrophic cardiomyopathy.
23 domain of the myosin heavy chain that cause familial hypertrophic cardiomyopathy.
24 f the beta-cardiac myosin heavy chain causes familial hypertrophic cardiomyopathy.
25 C were determined in unrelated patients with familial hypertrophic cardiomyopathy.
26 unt for approximately 15 percent of cases of familial hypertrophic cardiomyopathy.
27 encoding human cardiac troponin T can cause familial hypertrophic cardiomyopathy, a disease that is
28 nin T (TnT) I79N mutation has been linked to familial hypertrophic cardiomyopathy and a high incidenc
29 ofilament Ca sensitivity are associated with familial hypertrophic cardiomyopathy and confer a high r
30 nin T (TnT) I79N mutation has been linked to familial hypertrophic cardiomyopathy and high incidence
31 strated by the implications to be drawn from familial hypertrophic cardiomyopathy and the 50 new gene
32 d patients with hereditary long QT syndrome, familial hypertrophic cardiomyopathy, and familial dilat
33 Fifteen percent of the mutations causing familial hypertrophic cardiomyopathy are in the troponin
34 d lines develop a pathology similar to human familial hypertrophic cardiomyopathy but within a dramat
36 We also propose that mice bearing homozygous familial hypertrophic cardiomyopathy-causing mutations m
37 f all of the known cTnT mutations that cause familial hypertrophic cardiomyopathy fall within the TNT
38 To test this hypothesis, we utilized the familial hypertrophic cardiomyopathy (FHC) alpha-Tm E180
40 hemodynamic abnormalities characteristic of familial hypertrophic cardiomyopathy (FHC) and sudden de
41 studied the clinical and genetic features of familial hypertrophic cardiomyopathy (FHC) caused by an
45 T) F110I and R278C mutations associated with familial hypertrophic cardiomyopathy (FHC) in humans.
46 runc) in the cardiac troponin T (cTnT) model familial hypertrophic cardiomyopathy (FHC) in humans.
47 , Arg403Gln (R403Q), causes a severe form of familial hypertrophic cardiomyopathy (FHC) in humans.
58 fect of troponin (Tn) T mutations that cause familial hypertrophic cardiomyopathy (FHC) on cardiac mu
59 light chain (RLC) shown to cause a malignant familial hypertrophic cardiomyopathy (FHC) phenotype wer
60 on-contraction coupling in cardiac muscle of familial hypertrophic cardiomyopathy (FHC) remains poorl
62 sin regulatory light chain (RLC) gene causes familial hypertrophic cardiomyopathy (FHC) with a phenot
63 ative sarcomere protein gene mutations cause familial hypertrophic cardiomyopathy (FHC), a disease ch
64 (MHC) was the first mutation to be linked to familial hypertrophic cardiomyopathy (FHC), a primary di
65 light chain (RLC) lead to the development of familial hypertrophic cardiomyopathy (FHC), an autosomal
66 e of the sarcomeric proteins associated with familial hypertrophic cardiomyopathy (FHC), an autosomal
67 e dilated cardiomyopathy(DCM) independent of familial hypertrophic cardiomyopathy (FHC), and TnT-K273
68 chain gene (MYH7) have been associated with familial hypertrophic cardiomyopathy (FHC), but no study
69 ion as well as the molecular pathogenesis of familial hypertrophic cardiomyopathy (FHC), eight FHC-li
70 hough sarcomere protein gene mutations cause familial hypertrophic cardiomyopathy (FHC), individuals
71 a tropomyosin (TM) mutation associated with familial hypertrophic cardiomyopathy (FHC), we generated
83 hypertrophy (LVH), the clinical hallmark of familial hypertrophic cardiomyopathy (FHCM), is absent i
87 stand the clinical and molecular features of familial hypertrophic cardiomyopathy (HCM) in which a mi
92 he discovery of the first mutation linked to familial hypertrophic cardiomyopathy (HCM), an astonishi
94 se results suggest that the primary cause of familial hypertrophic cardiomyopathy, in some cases, is
98 iac myosin binding protein-C or titin, cause familial hypertrophic cardiomyopathies, it is important
99 ac failure, Galphaq overexpression and human familial hypertrophic cardiomyopathy mutant myosin bindi
102 , and alpha-tropomyosin account for > 45% of familial hypertrophic cardiomyopathy, none were found he
105 ta14 mutation of troponin T, associated with familial hypertrophic cardiomyopathy, results in an incr
106 in T are responsible for 15% of all cases of familial hypertrophic cardiomyopathy, the leading cause
107 n (Tn)T and alpha-tropomyosin were linked to familial hypertrophic cardiomyopathy, thus transforming
108 To understand further the pathogenesis of familial hypertrophic cardiomyopathy, we determined how
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。